Parnax Lab Share Price

CMP as on25-Oct-21 15:18

₹ 25.15
-0.75 -2.9%

Open

₹ 25.10

Turnover (lac)

Prev. Close

₹ 25.90

Day's Vol (shares)

₹ 1,691

Day's Range

₹ 25.10
₹ 25.70

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 06-Aug-2021 - -
Quarterly Results Outcome of Board Meeting held on 14th August, 2021 (As Per BSE Announcement Dated on 14/08/2021)
Board Meeting - 23-Jun-2021 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2021 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Wednesday, 30th June, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and year ended 31st March, 2021. 2. Considered and took note of Limited Review Report for the quarter and year ended 31st March 2021. The Meeting was commenced at 5.00 p.m. and concluded at 9.40 p.m. Kindly take the same on your record. (AS Per BSE Announcement Dated on 30.06.2021)
Board Meeting - 21-Jun-2021 - -
Dear Sir, This is to inform you that in the meeting of the Board of Directors of the Company Parnax Lab Limited held on 21st June, 2021, Mrs. Preet Vijay Kukreja has been appointed as the Key Managerial Personnel (Company Secretary and Compliance Officer) w.e.f. 21st June, 2021. The meeting commenced at 6.30 p.m. concluded at 7.00 p.m. This is for your information. Kindly take the same on your record.
Board Meeting - 28-May-2021 - -
In terms of Regulation 30(2) read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we wish to inform you that on the recommendations of Nomination and Remuneration Committee, the Board of Directors of the Company, in their meeting held today i.e., 28th May, 2021 has inter-alia considered and approved the appointment of Mr. Yogesh Varia (DIN:09186184) as an Additional Director (Non-Executive Independent Director) of the Company for a term of five (5) consecutive years w.e.f. 28th May, 2021 subject to the approval of shareholders at the ensuing Annual General Meeting.
Board Meeting - 03-Feb-2021 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Saturday, 13th February, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and nine months ended 31st December, 2020. 2. Considered and took note of Limited Review Report for the quarter and nine months ended 31st December, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 5.00 p.m. Kindly take the same on your record (As per BSE Announcement Dated on 13/2/2021)
Board Meeting - 03-Nov-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter and half year ended 30th September 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Thursday,12th November 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and half year ended 30th September, 2020. 2. Considered and took note of Limited Review Report for the quarter and half year ended September 30, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 7.00 p.m. Kindly take the same on your record. Thanking You, (As per BSE Announcement Dated on 12/11/2020)
Open ZERO Brokerage Demat Account